Literature DB >> 2416838

Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.

Y Fujii, J Hashimoto, Y Monden, T Ito, K Nakahara, Y Kawashima.   

Abstract

In 13 patients with myasthenia gravis, spontaneous in vitro production of antibody to acetylcholine receptor (AChR) by thymic cells was observed in seven patients, by bone marrow cells in nine, by peripheral blood cells (PBL) in six, and by lymph node cells in nine. The rate of anti-AChR production in culture closely correlated with the serum anti-AChR level. Specific activity of the immunoglobulin (Ig) G spontaneously produced (anti-AChR/total IgG) was about 10-fold higher in the thymus than in bone marrow, peripheral blood, or lymph node cultures. Pokeweed mitogen (PWM) enhanced anti-AChR production only by PBL. With neither thymus nor lymph node cells did PWM stimulate anti-AChR production, although it greatly enhanced total IgG production. In bone marrow, it depressed both, and it appeared that the anti-AChR was derived from long-lived plasma cells that may be responsible for delaying the fall of serum anti-AChR levels after thymectomy. The results suggest that AChR-specific cells are selectively activated in the thymus, and this may help to explain the benefits of thymectomy in myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2416838

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.

Authors:  Arnold I Levinson; Yi Zheng; Glen Gaulton; Decheng Song; Jonni Moore; C Hank Pletcher
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.

Authors:  Y Fujii; M Hayakawa; K Nakahara
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

Review 3.  Surgery of the thymus in Japan.

Authors:  Yoshitaka Fujii
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-03-12

Review 4.  Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.

Authors:  Frédérique Truffault; Vincent de Montpreville; Bruno Eymard; Tarek Sharshar; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 5.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

6.  Phenotypic characteristics of thymic B lymphocytes in myasthenia gravis.

Authors:  B Zweiman; A I Levinson; R P Lisak
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

Review 7.  B cells in the pathophysiology of myasthenia gravis.

Authors:  John S Yi; Jeffrey T Guptill; Panos Stathopoulos; Richard J Nowak; Kevin C O'Connor
Journal:  Muscle Nerve       Date:  2017-09-30       Impact factor: 3.217

8.  Acetylcholine-receptor-like protein from human thymoma associated with myasthenia gravis.

Authors:  S Kawanami; H Kamei; J Oita; M Kurokawa; Y Uchida; K Hayashi
Journal:  J Neurol       Date:  1987-05       Impact factor: 4.849

9.  Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis.

Authors:  Ruoyi Jiang; Kenneth B Hoehn; Casey S Lee; Minh C Pham; Robert J Homer; Frank C Detterbeck; Inmaculada Aban; Leslie Jacobson; Angela Vincent; Richard J Nowak; Henry J Kaminski; Steven H Kleinstein; Kevin C O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-16       Impact factor: 11.205

10.  The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.

Authors:  E Meinl; W E Klinkert; H Wekerle
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.